15-65029595-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_139242.4(MTFMT):c.19C>G(p.Arg7Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000103 in 1,452,192 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_139242.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTFMT | NM_139242.4 | c.19C>G | p.Arg7Gly | missense_variant | Exon 1 of 9 | ENST00000220058.9 | NP_640335.2 | |
MTFMT | XM_005254158.6 | c.19C>G | p.Arg7Gly | missense_variant | Exon 1 of 9 | XP_005254215.2 | ||
MTFMT | XR_001751081.2 | n.45C>G | non_coding_transcript_exon_variant | Exon 1 of 5 | ||||
MTFMT | XR_007064421.1 | n.45C>G | non_coding_transcript_exon_variant | Exon 1 of 4 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151900Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000389 AC: 3AN: 77132Hom.: 0 AF XY: 0.0000451 AC XY: 2AN XY: 44308
GnomAD4 exome AF: 0.00000923 AC: 12AN: 1300292Hom.: 0 Cov.: 32 AF XY: 0.00000941 AC XY: 6AN XY: 637450
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151900Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74176
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.19C>G (p.R7G) alteration is located in exon 1 (coding exon 1) of the MTFMT gene. This alteration results from a C to G substitution at nucleotide position 19, causing the arginine (R) at amino acid position 7 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Combined oxidative phosphorylation defect type 15 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at